ARCHIVES

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

This article is from The Cancer Letter archive.

Vol. 32 No. 37 | October 20, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Holds Paylines To 160, 165 for Now While Anticipating Another OMB Rescission Request

November 14, 1986

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

Breast Cancer Action Claims “Victory On Avastin.”

December 14, 2007

M.D. Anderson, SWOG To Use Web-Based Software To Expand Access To Trials.

September 29, 2000

Varmus, In Letter To Institute Pasteur, Reopens Discussion Of Test Kit Royalties

July 1, 1994

NTP Board Okays Modification Of Bioassay Protocols

April 9, 1982